BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Diego M, Correa D, Mennickent S, Godoy R, Vergara C. Determination of vortioxetine and its degradation product in bulk and tablets, by LC-DAD and MS/MS methods. Biomed Chromatogr 2018;32:e4340. [PMID: 30001570 DOI: 10.1002/bmc.4340] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Petruczynik A, Wróblewski K, Wojtanowski K, Mroczek T, Juchnowicz D, Karakuła-Juchnowicz H, Tuzimski T. Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS. Molecules 2020;25:E2483. [PMID: 32471141 DOI: 10.3390/molecules25112483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Modhave D, Barrios B, Paudel A. PVP-H2O2 Complex as a New Stressor for the Accelerated Oxidation Study of Pharmaceutical Solids. Pharmaceutics 2019;11:E457. [PMID: 31484442 DOI: 10.3390/pharmaceutics11090457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ragi NC, Velma GR, Pallerla PK, Siddiqua S, Alugonda V, Rachamalla HKR, Pabbaraja S, Sripadi P. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR. J Pharm Biomed Anal 2020;188:113442. [PMID: 32622114 DOI: 10.1016/j.jpba.2020.113442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Atila Karaca S, Rashidova N, Uğur A, Yeniceli Uğur D. Development of a simple HPLC method for the quantitation of vortioxetine in pharmaceuticals using DoE approach. Chem Pap 2020;74:1541-9. [DOI: 10.1007/s11696-019-01008-0] [Reference Citation Analysis]